Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients

Annals of Oncology

Volumn 5, Issue 3, 1994, Pages 253-258

  Joss, R A ^a   Bacchi, M ^b   Buser, K ^c   Kirchner, V ^d   Neuenschwander, H ^e   Orth, B ^f   Aapro, M S ^d   Thurlimann B ^g  

^a LUZERNER KANTONSSPITAL   (Switzerland)

^b SAKK Operations Office ^*  (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e OSPEDALE SAN GIOVANNI   (Switzerland)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Chemotherapy; Delayed emesis; Dexamethasone; Nausea; Ondansetron; Vomiting

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DEXAMETHASONE; ONDANSETRON; PLACEBO;

ADULT; AGED; ARTICLE; CARCINOMA; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; EPIGASTRIC PAIN; FEMALE; FLUSHING; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VOMITING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NAUSEA; ONDANSETRON; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VOMITING;

EID: 0028350397     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a058803     Document Type: Article

References (0)